Proof‐of‐Concept Study to Assess the Nociceptin Receptor Antagonist LY2940094 as a New Treatment for Alcohol Dependence

E-ISSN： 1530-0277|40|9|1935-1944

ISSN： 0145-6008

Source： ALCOHOLISM (ELECTRONIC), Vol.40, Iss.9, 2016-09, pp. : 1935-1944

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of spontaneous preterm labour with retosiban: a phase 2 proof‐of‐concept study

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 4, 2015-10 ,pp. : 740-749

John Wiley & Sons Inc

Access to resources Recommend Favorite

Feedback-controlled robotics-assisted treadmill exercise to assess and influence aerobic capacity early after stroke: a proof-of-concept study

By Stoller Oliver Schindelholz Matthias Bichsel Lukas Schuster Corina de Bie Rob A. de Bruin Eling D. Hunt Kenneth J.

Disability and Rehabilitation: Assistive Technology, Vol. 9, Iss. 4, 2014-07 ,pp. : 271-278

Informa Healthcare

Access to resources Recommend Favorite

Orexin Receptor Antagonism, a New Sleep‐Enabling Paradigm: A Proof‐of‐Concept Clinical Trial

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 6, 2012-06 ,pp. : 975-985

John Wiley & Sons Inc

Access to resources Recommend Favorite

Receptive Music Therapy for the Treatment of Depression: A Proof-of-Concept Study and Prospective Controlled Clinical Trial of Efficacy

Psychotherapy and Psychosomatics, Vol. 79, Iss. 5, 2010-08 ,pp. : 321-322

Karger

Access to resources Recommend Favorite

Effective Biomarkers for Proof-of-Concept

Current Medical Imaging Reviews, Vol. 4, Iss. 1, 2008-02 ,pp. : 25-27

Bentham Science Publishers

Access to resources Recommend Favorite